The Multifaceted Role of Regulatory T Cells in Breast Cancer
The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to control tumor growth and metastasis, tumor-corrupted immunosuppressive immune cells strive to impair effective immunity and promote tumor progre...
Uložené v:
| Vydané v: | Annual review of cancer biology Ročník 5; s. 291 |
|---|---|
| Hlavní autori: | , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
04.03.2021
|
| Predmet: | |
| ISSN: | 2472-3428, 2472-3428 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to control tumor growth and metastasis, tumor-corrupted immunosuppressive immune cells strive to impair effective immunity and promote tumor progression. Of these, regulatory T cells (T
), the gatekeepers of immune homeostasis, emerge as multifaceted players involved in breast cancer. Intriguingly, clinical observations suggest that blood and intratumoral T
can have strong prognostic value, dictated by breast cancer subtype. Accordingly, emerging preclinical evidence shows that T
occupy a central role in breast cancer initiation and progression and provide critical support to metastasis formation. Here, T
are not only important for immune escape but also promote tumor progression independent of their immune regulatory capacity. Combining insights into T
biology with advances made across the rapidly growing field of immuno-oncology is expected to set the stage for the design of more effective immunotherapy strategies. |
|---|---|
| AbstractList | The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to control tumor growth and metastasis, tumor-corrupted immunosuppressive immune cells strive to impair effective immunity and promote tumor progression. Of these, regulatory T cells (T
), the gatekeepers of immune homeostasis, emerge as multifaceted players involved in breast cancer. Intriguingly, clinical observations suggest that blood and intratumoral T
can have strong prognostic value, dictated by breast cancer subtype. Accordingly, emerging preclinical evidence shows that T
occupy a central role in breast cancer initiation and progression and provide critical support to metastasis formation. Here, T
are not only important for immune escape but also promote tumor progression independent of their immune regulatory capacity. Combining insights into T
biology with advances made across the rapidly growing field of immuno-oncology is expected to set the stage for the design of more effective immunotherapy strategies. The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to control tumor growth and metastasis, tumor-corrupted immunosuppressive immune cells strive to impair effective immunity and promote tumor progression. Of these, regulatory T cells (Tregs), the gatekeepers of immune homeostasis, emerge as multifaceted players involved in breast cancer. Intriguingly, clinical observations suggest that blood and intratumoral Tregs can have strong prognostic value, dictated by breast cancer subtype. Accordingly, emerging preclinical evidence shows that Tregs occupy a central role in breast cancer initiation and progression and provide critical support to metastasis formation. Here, Tregs are not only important for immune escape but also promote tumor progression independent of their immune regulatory capacity. Combining insights into Treg biology with advances made across the rapidly growing field of immuno-oncology is expected to set the stage for the design of more effective immunotherapy strategies.The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to control tumor growth and metastasis, tumor-corrupted immunosuppressive immune cells strive to impair effective immunity and promote tumor progression. Of these, regulatory T cells (Tregs), the gatekeepers of immune homeostasis, emerge as multifaceted players involved in breast cancer. Intriguingly, clinical observations suggest that blood and intratumoral Tregs can have strong prognostic value, dictated by breast cancer subtype. Accordingly, emerging preclinical evidence shows that Tregs occupy a central role in breast cancer initiation and progression and provide critical support to metastasis formation. Here, Tregs are not only important for immune escape but also promote tumor progression independent of their immune regulatory capacity. Combining insights into Treg biology with advances made across the rapidly growing field of immuno-oncology is expected to set the stage for the design of more effective immunotherapy strategies. |
| Author | Kos, Kevin de Visser, Karin E |
| Author_xml | – sequence: 1 givenname: Kevin surname: Kos fullname: Kos, Kevin organization: Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands – sequence: 2 givenname: Karin E surname: de Visser fullname: de Visser, Karin E organization: Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34632244$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj11LwzAUhoNMnM79Bcmd3kST0zRtwBstfsFEGPO6ZMmpVrpkJq2wf2_RCfLCOefi4fC8J2Tig0dCzgW_FEKqK-P9EPGLWeMtxnUbGJeggTPBpRZwQI5BFsAyCeXk3z0l85Q-OOeiUOPgR2SaSZUBSHlMrlfvSJ-Hrm8bY7FHR5ehQxoausS3oTN9iDu6ohV2XaKtp7cRTepp9aNwSg4b0yWc7_eMvN7frapHtnh5eKpuFszkHHqWSyUcOJ03GV8blE6K0mQKVGHHOMct16BVaUxpi7wUVkPuFGorlQU7is7Ixe_fbQyfA6a-3rTJjkrGYxhSDXnJteIiEyN6tkeH9QZdvY3txsRd_dcYvgFnD14_ |
| CitedBy_id | crossref_primary_10_1016_j_phrs_2025_107687 crossref_primary_10_1186_s12967_024_05104_y crossref_primary_10_1186_s13058_022_01537_9 crossref_primary_10_1016_j_immuni_2025_07_008 crossref_primary_10_1016_j_immuni_2022_05_011 crossref_primary_10_1016_j_prp_2022_154127 crossref_primary_10_1158_0008_5472_CAN_22_0654 crossref_primary_10_1186_s12943_022_01656_z crossref_primary_10_1016_j_prp_2023_154349 crossref_primary_10_1038_s43018_023_00521_2 crossref_primary_10_3390_ijms252413697 crossref_primary_10_1016_j_drudis_2024_104254 crossref_primary_10_1016_j_jncc_2024_12_008 crossref_primary_10_1186_s43163_024_00658_6 crossref_primary_10_1002_adbi_202400140 crossref_primary_10_1016_j_cyto_2022_156106 crossref_primary_10_3390_biomedicines13051173 crossref_primary_10_3390_vaccines10101764 crossref_primary_10_1002_mc_23730 crossref_primary_10_1038_s41598_023_47816_z crossref_primary_10_3390_cancers16010124 crossref_primary_10_1080_2162402X_2022_2063225 crossref_primary_10_3390_cancers14194885 crossref_primary_10_1080_08820139_2025_2547691 crossref_primary_10_1186_s13046_025_03394_8 crossref_primary_10_1002_cam4_6757 crossref_primary_10_1080_2162402X_2023_2201147 crossref_primary_10_1007_s12282_023_01491_0 crossref_primary_10_1038_s41467_024_54874_y crossref_primary_10_1080_14728222_2024_2427038 crossref_primary_10_3390_cancers15041346 crossref_primary_10_1038_s41523_025_00721_2 crossref_primary_10_3233_BD_239002 crossref_primary_10_1016_j_celrep_2024_114377 crossref_primary_10_2298_AOO241217003B |
| ContentType | Journal Article |
| DBID | NPM 7X8 |
| DOI | 10.1146/annurev-cancerbio-042920-104912 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2472-3428 |
| ExternalDocumentID | 34632244 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: ZonMw grantid: 91819616 – fundername: European Research Council grantid: 615300 |
| GroupedDBID | -QD 0R~ 1KX 51A AAGWO AAQMF AARJV AAWJP AAXSQ ABDOG ABGRM ABVYV ACGFS ACJYF ACKHT ACPHO ACQCJ ACQLW ACRLM ADLON AEAIQ AEKBM AFERR AFONB AHKZM AICBU AJAAW ALAFQ ALMA_UNASSIGNED_HOLDINGS AOUBY ATAUN BCFVH BJPMW BMYRD EBS EJD FXG M22 NPM O9- OK1 RAR ZYWBE 7X8 RIG |
| ID | FETCH-LOGICAL-a502t-5461d2d95f30bae4d418a36267c7c7dd0c092968aa8c7581c925d6e9c46c2c322 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 38 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000627716400016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2472-3428 |
| IngestDate | Sun Sep 28 01:15:03 EDT 2025 Sat May 31 02:10:43 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | breast cancer immunosuppression regulatory T cell tumor microenvironment metastasis |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a502t-5461d2d95f30bae4d418a36267c7c7dd0c092968aa8c7581c925d6e9c46c2c322 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.annualreviews.org/content/journals/10.1146/annurev-cancerbio-042920-104912 |
| PMID | 34632244 |
| PQID | 2580960131 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2580960131 pubmed_primary_34632244 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-03-04 |
| PublicationDateYYYYMMDD | 2021-03-04 |
| PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-04 day: 04 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Annual review of cancer biology |
| PublicationTitleAlternate | Annu Rev Cancer Biol |
| PublicationYear | 2021 |
| SSID | ssj0001760010 |
| Score | 2.3566692 |
| SecondaryResourceType | review_article |
| Snippet | The microenvironment of breast cancer hosts a dynamic cross talk between diverse players of the immune system. While cytotoxic immune cells are equipped to... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 291 |
| Title | The Multifaceted Role of Regulatory T Cells in Breast Cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34632244 https://www.proquest.com/docview/2580960131 |
| Volume | 5 |
| WOSCitedRecordID | wos000627716400016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD6oE_HF-2XeiCD4FGwubRoQRIfDl40xJuxtpEkKg9HOdQr-e5O0Y0-CIIW-lbaHL1-_nnNyPoA7xQT3QhgTQxTmMmWeByXmQpgoMyJjPA9mE6LfT8djOWgSblXTVrnixEDUptQ-R_5A49SrbcLI0_wDe9coX11tLDQ2ocWclPGoFuN0nWPxVacwkIByQTFzUnsH7psBuSufF6x9eBfZtMRR8G5yzMSld6j8TXKGT093_78PfQB7jehEzzVKDmHDFkew02vK6sfw6MCCwlbcXGmnog0aljOLyhwNa6v6cvGNRqhjZ7MKTQv04jvZl6gTXukE3ruvo84bbmwVsIojusQxT4ihRsY5izJlueEkVX4qjdDuMCbSkdNMSapUqt3fBNGSxiaxUvNEU-0I4BS2irKw54D8rt6MRTlXTglIorI0ltZIRXIRW2FtG25XcZk42PpahCps-VlN1pFpw1kd3Mm8nq8xYTxxd-H84g9XX8Iu9V0mviuMX0Erd4vWXsO2_lpOq8VNwIM79we9HzNDvJw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Multifaceted+Role+of+Regulatory+T+Cells+in+Breast+Cancer&rft.jtitle=Annual+review+of+cancer+biology&rft.au=Kos%2C+Kevin&rft.au=de+Visser%2C+Karin+E&rft.date=2021-03-04&rft.issn=2472-3428&rft.eissn=2472-3428&rft.volume=5&rft.spage=291&rft_id=info:doi/10.1146%2Fannurev-cancerbio-042920-104912&rft_id=info%3Apmid%2F34632244&rft_id=info%3Apmid%2F34632244&rft.externalDocID=34632244 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2472-3428&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2472-3428&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2472-3428&client=summon |